{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:38:50Z","timestamp":1788928730994,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00115-024-01644-2","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T17:02:33Z","timestamp":1710867753000},"page":"376-384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Klinik und Diagnostik humaner spongiformer Enzephalopathien: ein Update","Clinical characteristics and diagnostics of human spongiform encephalopathies: an update"],"prefix":"10.1007","volume":"95","author":[{"given":"Peter","family":"Hermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"issue":"23","key":"1644_CR1","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner\u00a0SB (1998) Prions. Proc Natl Acad Sci U S\u00a0A 95(23):13363\u201313383. https:\/\/doi.org\/10.1073\/pnas.95.23.13363","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1644_CR2","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/nan.12592","volume":"46","author":"Z Jaunmuktane","year":"2020","unstructured":"Jaunmuktane\u00a0Z, Brandner\u00a0S (2020) Invited review: the role of prion-like mechanisms in neurodegenerative diseases. Neuropathol Appl Neurobiol 46:522\u2013545. https:\/\/doi.org\/10.1111\/nan.12592","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1644_CR3","doi-asserted-by":"publisher","DOI":"10.1159\/000535112","author":"P Hermann","year":"2023","unstructured":"Hermann\u00a0P, B\u00f6hnke\u00a0J, Bunck\u00a0T et\u00a0al (2023) Effect of SARS-CoV\u20112 incidence and immunisation rates on sporadic Creutzfeldt-Jakob disease incidence. Neuroepidemiology. https:\/\/doi.org\/10.1159\/000535112","journal-title":"Neuroepidemiology"},{"key":"1644_CR4","doi-asserted-by":"publisher","first-page":"e1017","DOI":"10.1212\/WNL.0000000000010086","volume":"95","author":"DD Rhoads","year":"2020","unstructured":"Rhoads\u00a0DD, Wrona\u00a0A, Foutz\u00a0A et\u00a0al (2020) Neurology 95:e1017\u2013e1026. https:\/\/doi.org\/10.1212\/WNL.0000000000010086","journal-title":"Neurology"},{"key":"1644_CR5","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/S1473-3099(19)30615-2","volume":"20","author":"L Uttley","year":"2020","unstructured":"Uttley\u00a0L, Carroll\u00a0C, Wong\u00a0R et\u00a0al (2020) Creutzfeldt-Jakob disease: a\u00a0systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis 20:e2\u2013e10. https:\/\/doi.org\/10.1016\/S1473-3099(19)30615-2","journal-title":"Lancet Infect Dis"},{"key":"1644_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41582-021-00488-7","volume":"17","author":"N Watson","year":"2021","unstructured":"Watson\u00a0N, Brandel\u00a0JP, Green\u00a0A et\u00a0al (2021) The importance of ongoing international surveillance for Creutzfeldt-Jakob disease. Nat Rev Neurol 17:362\u2013379. https:\/\/doi.org\/10.1038\/s41582-021-00488-7","journal-title":"Nat Rev Neurol"},{"key":"1644_CR7","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1093\/brain\/awl159","volume":"129","author":"SJ Collins","year":"2006","unstructured":"Collins\u00a0SJ, Sanchez-Juan\u00a0P, Masters\u00a0CL et\u00a0al (2006) Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 129:2278\u20132287. https:\/\/doi.org\/10.1093\/brain\/awl159","journal-title":"Brain"},{"key":"1644_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","volume":"124","author":"P Parchi","year":"2012","unstructured":"Parchi\u00a0P, de Boni\u00a0L, Saverioni\u00a0D et\u00a0al (2012) Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124:517\u2013529. https:\/\/doi.org\/10.1007\/s00401-012-1002-8","journal-title":"Acta Neuropathol"},{"key":"1644_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/B978-0-444-63945-5.00013-1","volume":"153","author":"A Ladogana","year":"2018","unstructured":"Ladogana\u00a0A, Kovacs\u00a0GG (2018) Genetic Creutzfeldt-Jakob disease. Handb Clin Neurol 153:219\u2013242. https:\/\/doi.org\/10.1016\/B978-0-444-63945-5.00013-1","journal-title":"Handb Clin Neurol"},{"key":"1644_CR10","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/s0140-6736(99)01342-2","volume":"353","author":"A Alperovitch","year":"1999","unstructured":"Alperovitch\u00a0A, Zerr\u00a0I, Pocchiari\u00a0M et\u00a0al (1999) Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 353:1673\u20131674. https:\/\/doi.org\/10.1016\/s0140-6736(99)01342-2","journal-title":"Lancet"},{"key":"1644_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi\u00a0P, Giese\u00a0A, Capellari\u00a0S et\u00a0al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224\u2013233","journal-title":"Ann Neurol"},{"key":"1644_CR12","unstructured":"Zerr I et\u00a0al Creutzfeldt-Jakob-Krankheit, S1-Leitlinie, 2018; in: Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg.), Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. www.dgn.org\/leitlinien. Zugegriffen: 10. Jan. 2024"},{"key":"1644_CR13","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/ana.20261","volume":"56","author":"BJ Steinhoff","year":"2004","unstructured":"Steinhoff\u00a0BJ, Zerr\u00a0I, Glatting\u00a0M et\u00a0al (2004) Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol 56:702\u2013708. https:\/\/doi.org\/10.1002\/ana.20261","journal-title":"Ann Neurol"},{"key":"1644_CR14","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr\u00a0I, Kallenberg\u00a0K, Summers\u00a0DM et\u00a0al (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132:2659\u20132668. https:\/\/doi.org\/10.1093\/brain\/awp191","journal-title":"Brain"},{"key":"1644_CR15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.25983","volume":"89","author":"A Bizzi","year":"2021","unstructured":"Bizzi\u00a0A, Pascuzzo\u00a0R, Blevins\u00a0J et\u00a0al (2021) Subtype diagnosis of sporadic Creutzfeldt-Jakob disease with diffusion magnetic resonance imaging. Ann Neurol 89:560\u2013572. https:\/\/doi.org\/10.1002\/ana.25983","journal-title":"Ann Neurol"},{"key":"1644_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1468-1331.2006.01630.x","volume":"14","author":"A Green","year":"2007","unstructured":"Green\u00a0A, Sanchez-Juan\u00a0P, Ladogana\u00a0A et\u00a0al (2007) CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies. Eur J Neurol 14:121\u2013124. https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01630.x","journal-title":"Eur J Neurol"},{"key":"1644_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/ana.22454","volume":"70","author":"N Chitravas","year":"2011","unstructured":"Chitravas\u00a0N, Jung\u00a0RS, Kofskey\u00a0DM et\u00a0al (2011) Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol 70:437\u2013444. https:\/\/doi.org\/10.1002\/ana.22454","journal-title":"Ann Neurol"},{"key":"1644_CR18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1212\/wnl.58.2.192","volume":"58","author":"M Otto","year":"2002","unstructured":"Otto\u00a0M, Wiltfang\u00a0J, Cepek\u00a0L et\u00a0al (2002) Tau protein and 14-3\u20113 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58:192\u2013197. https:\/\/doi.org\/10.1212\/wnl.58.2.192","journal-title":"Neurology"},{"key":"1644_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","volume":"20","author":"P Hermann","year":"2021","unstructured":"Hermann\u00a0P, Appleby\u00a0B, Brandel\u00a0JP et\u00a0al (2021) Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol 20:235\u2013246. https:\/\/doi.org\/10.1016\/S1474-4422(20)30477-4","journal-title":"Lancet Neurol"},{"key":"1644_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nm.2294","volume":"17","author":"R Atarashi","year":"2011","unstructured":"Atarashi\u00a0R, Satoh\u00a0K, Sano\u00a0K et\u00a0al (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17:175\u2013178. https:\/\/doi.org\/10.1038\/nm.2294","journal-title":"Nat Med"},{"key":"1644_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1315200","volume":"371","author":"CD Orr\u00fa","year":"2014","unstructured":"Orr\u00fa\u00a0CD, Bongianni\u00a0M, Tonoli\u00a0G et\u00a0al (2014) A test for Creutzfeldt-Jakob disease using nasal brushings. N\u00a0Engl J Med 371:519\u2013529. https:\/\/doi.org\/10.1056\/NEJMoa1315200","journal-title":"N Engl J Med"},{"key":"1644_CR22","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra2119323","volume":"386","author":"I Zerr","year":"2022","unstructured":"Zerr\u00a0I (2022) Laboratory diagnosis of Creutzfeldt-Jakob disease. N\u00a0Engl J Med 386:1345\u20131350. https:\/\/doi.org\/10.1056\/NEJMra2119323","journal-title":"N Engl J Med"},{"key":"1644_CR23","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1056\/NEJMc2214647","volume":"388","author":"M Schmitz","year":"2023","unstructured":"Schmitz\u00a0M, Correia\u00a0SS, Hermann\u00a0P et\u00a0al (2023) Detection of prion protein seeding activity in tear fluids. N\u00a0Engl J Med 388:1816\u20131817. https:\/\/doi.org\/10.1056\/NEJMc2214647","journal-title":"N Engl J Med"},{"key":"1644_CR24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1212\/01.wnl.0000113764.35026.ef","volume":"62","author":"M Otto","year":"2004","unstructured":"Otto\u00a0M, Cepek\u00a0L, Ratzka\u00a0P et\u00a0al (2004) Efficacy of flupirtine on cognitive function in patients with CJD: a\u00a0double-blind study. Neurology 62:714\u2013718. https:\/\/doi.org\/10.1212\/01.wnl.0000113764.35026.ef","journal-title":"Neurology"},{"key":"1644_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","volume":"13","author":"S Ha\u00efk","year":"2014","unstructured":"Ha\u00efk\u00a0S, Marcon\u00a0G, Mallet\u00a0A et\u00a0al (2014) Doxycycline in Creutzfeldt-Jakob disease: a\u00a0phase\u00a02, randomised, double-blind, placebo-controlled trial. Lancet Neurol 13:150\u2013158. https:\/\/doi.org\/10.1016\/S1474-4422(13)70307-7","journal-title":"Lancet Neurol"},{"key":"1644_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/jnnp-2016-313541","volume":"88","author":"D Varges","year":"2017","unstructured":"Varges\u00a0D, Manthey\u00a0H, Heinemann\u00a0U et\u00a0al (2017) Doxycycline in early CJD: a\u00a0double-blinded randomised phase\u00a0II and observational study. J\u00a0Neurol Neurosurg Psychiatry 88:119\u2013125. https:\/\/doi.org\/10.1136\/jnnp-2016-313541","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1644_CR27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S1474-4422(22)00082-5","volume":"21","author":"S Mead","year":"2022","unstructured":"Mead\u00a0S, Khalili-Shirazi\u00a0A, Potter\u00a0C et\u00a0al (2022) Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a\u00a0first-in-human treatment programme. Lancet Neurol 21:342\u2013354. https:\/\/doi.org\/10.1016\/S1474-4422(22)00082-5","journal-title":"Lancet Neurol"},{"key":"1644_CR28","doi-asserted-by":"publisher","first-page":"10615","DOI":"10.1093\/nar\/gkaa616","volume":"48","author":"EV Minikel","year":"2020","unstructured":"Minikel\u00a0EV, Zhao\u00a0HT, Le\u00a0J et\u00a0al (2020) Prion protein lowering is a\u00a0disease-modifying therapy across prion disease stages, strains and endpoints. Nucleic Acids Res 48:10615\u201310631. https:\/\/doi.org\/10.1093\/nar\/gkaa616","journal-title":"Nucleic Acids Res"},{"key":"1644_CR29","unstructured":"http:\/\/www.rki.de\/DE\/Content\/InfAZ\/C\/CJK\/CJK_node.html. Zugegriffen: 10. Jan. 2024"},{"key":"1644_CR30","unstructured":"http:\/\/www.cjd-goettingen.de. Zugegriffen: 10. Jan. 2024"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01644-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-024-01644-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01644-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T11:03:54Z","timestamp":1712919834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-024-01644-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1644"],"URL":"https:\/\/doi.org\/10.1007\/s00115-024-01644-2","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"28 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"I. Zerr: A.\u00a0Finanzielle Interessen: Die Universit\u00e4tsmedizin G\u00f6ttingen erh\u00e4lt von IONIS Pharmaceuticals Forschungsf\u00f6rderung f\u00fcr die klinische Auftragsforschung zu Prionerkrankungen. I.\u00a0Zerr gibt an, hierf\u00fcr als PI (Principal Investigator) zu fungieren. \u2013 B.\u00a0Nichtfinanzielle Interessen: Ober\u00e4rztin der Klinik f\u00fcr Neurologie, UMG G\u00f6ttingen; Leiterin des Klinischen Demenzzentrums, UMG G\u00f6ttingen; Leiterin des Nationalen Referenzzentrums f\u00fcr Transmissible Spongiforme Enzephalopathien, UM6 G\u00f6ttingen; Leiterin des Neurochemischen Labors, UMG G\u00f6ttingen. P.\u00a0Hermann: A.\u00a0Finanzielle Interessen: \u00dcbernachtungs- und Reisekosten f\u00fcr ein Investigator-Meeting im Vorfeld einer klinischen Studie von IONIS Pharmaceuticals. \u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Arzt, Nationales Referenzzentrum f\u00fcr Prionerkrankungen, Klinik f\u00fcr Neurologie, Universit\u00e4tsmedizin G\u00f6ttingen, G\u00f6ttingen. S.\u00a0Goebel: A.\u00a0Finanzielle Interessen: Die Universit\u00e4tsmedizin G\u00f6ttingen erh\u00e4lt von IONIS Pharmaceuticals Forschungsf\u00f6rderung f\u00fcr die klinische Auftragsforschung zu Prionerkrankungen. S.\u00a0Goebel gibt an, hierf\u00fcr als Studienarzt zu fungieren. \u2013 B.\u00a0Nichtfinanzielle Interessen: Arzt und wissenschaftlicher Mitarbeiter am Referenzzentrum f\u00fcr die Surveillance Transmissibler Spongiformer Enzephalopathien (NRZ TSE) der Klinik f\u00fcr Neurologie der Universit\u00e4tsmedizin G\u00f6ttingen (UMG). | Ich bin in keinen relevanten Vereinigungen Mitglied.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autorinnen und Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf . Der Verlag erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}